Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA

To report a multi-institutional case series of patients with advanced microsatellite instability high (MSI-H) prostate adenocarcinoma identified with clinical cell-free DNA (cfDNA) next-generation sequencing (NGS) testing and treated with immune checkpoint inhibitors. Retrospective analysis of patie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunother Cancer
Hlavní autoři: Barata, Pedro, Agarwal, Neeraj, Nussenzveig, Roberto, Gerendash, Benjamin, Jaeger, Ellen, Hatton, Whitley, Ledet, Elisa, Lewis, Brian, Layton, Jodi, Babiker, Hani, Bryce, Alan, Garje, Rohan, Stein, Cy, Kiedrowski, Lesli, Saylor, Philip, Sartor, Oliver
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2020
Témata:
Clinical/Translational Cancer Immunotherapy
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422632/
https://ncbi.nlm.nih.gov/pubmed/32788235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001065
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky